The FDA’s Rob Califf on importing drugs from Canada, on Aduhelm, and on opioids

The FDA commissioner has been busy with public appearances in recent days. Here’s what stood out to us from his remarks.

You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

Earmarks are back, and one state’s health care industry is cashing in

Read the rest…